A tale of two citrullines - Structural and functional aspects of myelin basic protein deimination in health and disease

Neurochemical Research

Volumn 32, Issue 2, 2007, Pages 137-158

  Harauz, George ^a   Musse, Abdiwahab A ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Citrulline; Deimination; Multiple sclerosis; Myelin; Myelin basic protein; Peptidylarginine deiminase; Rheumatoid arthritis

Indexed keywords

CITRULLINE; LIPID; MYELIN BASIC PROTEIN;

AUTOIMMUNE DISEASE; CENTRAL NERVOUS SYSTEM; GENERAL ASPECTS OF DISEASE; HEALTH; HUMAN; MOLECULE; MULTIPLE SCLEROSIS; MYELIN SHEATH; NERVE DEGENERATION; OLIGODENDROGLIA; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; ARTHRITIS, RHEUMATOID; CITRULLINE; HUMANS; HYDROLASES; MOLECULAR SEQUENCE DATA; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; MYELIN SHEATH; PROTEIN CONFORMATION; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 33846927285     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-006-9108-9     Document Type: Review

References (281)

1. Bates IR, Libich DS, Wood DD, Moscarello MA, Harauz G (2002) An Arg/Lys → Gln mutant of recombinant murine myelin basic protein as a mimic of the deiminated form implicated in multiple sclerosis. Protein Expr Purif 25:330-341
2. Bates IR, Harauz G (2003) Molecular dynamics exposes alpha-helices in myelin basic protein. J Mol Model (Online) 9:290-297
3. Curis E, Nicolis I, Moinard C, Osowska S, Zerrouk N, Benazeth S, Cynober L (2005) Almost all about citrulline in mammals. Amino Acids 29:177-205
4. Voet D, Voet JG (2004) Biochemistry. Wiley, New York
5. Ochoa JL, Porath J, Kempf J, Egly JM (1980) Electron donor-acceptor properties of urea and its role in charge-transfer chromatography. J Chromatogr 188:257-261
6. Mizutani Y, Kamogawa K, Nakanishi K (1989) Effect of urea on hydrophobic interaction - Raman difference spectroscopy on the C-H stretching vibration of acetone and the C-N stretching vibration of urea. J Phys Chem 93:5650-5654
7. Takahara K, Akashi K, Yokota A (2005) Purification and characterization of glutamate N-acetyltransferase involved in citrulline accumulation in wild watermelon. FEBS J 272:5353-5364
8. Legrain C, Stalon V, Noullez JP, Mercenier A, Simon JP, Broman K, Wiame JM (1977) Structure and function of ornithine carbamoyltransferases. Eur J Biochem 80:401-409
9. Iwanaga T, Yamazaki T, Kominami S (1999) Kinetic studies on the successive reaction of neuronal nitric oxide synthase from L-arginine to nitric oxide and L-citrulline. Biochemistry 38:16629-16635
10. Shibatani T, Kakimoto T, Chibata I (1975) Crystallization and properties of L-arginine deiminase of Pseudomonas putida. J Biol Chem 250:4580-4583
11. Smith DW, Ganaway RL, Fahrney DE (1978) Arginine deiminase from Mycoplasma arthritidis. Structure-activity relationships among substrates and competitive inhibitors. J Biol Chem 253:6016-6020
12. Zuniga M, Perez G, Gonzalez-Candelas F (2002) Evolution of arginine deiminase (ADI) pathway genes. Mol Phylogenet Evol 25:429-444
13. Lu X, Galkin A, Herzberg O, Dunaway-Mariano D (2004) Arginine deiminase uses an active-site cysteine in nucleophilic catalysis of L-arginine hydrolysis. J Am Chem Soc 126:5374-5375
14. Galkin A, Kulakova L, Sarikaya E, Lim K, Howard A, Herzberg O (2004) Structural insight into arginine degradation by arginine deiminase, an antibacterial and parasite drug target. J Biol Chem 279:14001-14008
15. Lu X, Li L, Wu R, Feng X, Li Z, Yang H, Wang C, Guo H, Galkin A, Herzberg O, Mariano PS, Martin BM, Dunaway-Mariano D (2006) Kinetic analysis of Pseudomonas aeruginosa arginine deiminase mutants and alternate substrates provides insight into structural determinants of function. Biochemistry 45:1162-1172
16. Gruening P, Fulde M, Valentin-Weigand P, Goethe R (2006) Structure, regulation, and putative function of the arginine deiminase system of Streptococcus suis. J Bacteriol 188:361-369
17. G-dimethylarginine dimethylaminohydrolase, from rat kidney. J Biol Chem 264:10205-10209
18. Knipp M, Vasak M (2000) A colorimetric 96-well microtiter plate assay for the determination of enzymatically formed citrulline. Anal Biochem 286:257-264
19. Balandraud N, Gouret P, Danchin EG, Blanc M, Zinn D, Roudier J, Pontarotti P (2005) A rigorous method for multigenic families' functional annotation: the peptidyl arginine deiminase (PADs) proteins family example. BMC Genomics 6:153
20. Vossenaar ER, Zendman AJ, van Venrooij WJ, Pruijn GJ (2003) PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays 25:1106-1118
21. Arita K, Hashimoto H, Shimizu T, Yamada M, Sato M (2003) Crystallization and preliminary X-ray crystallographic analysis of human peptidylarginine deiminase V. Acta Crystallogr D Biol Crystallogr 59:2332-2333
22. Arita K, Hashimoto H, Shimizu T, Nakashima K, Yamada M, Sato M (2004) Structural basis for Ca(2+)-induced activation of human PAD4. Nat Struct Mol Biol 11:777-783
23. Kearney PL, Bhatia M, Jones NG, Yuan L, Glascock MC, Catchings KL, Yamada M, Thompson PR (2005) Kinetic characterization of protein arginine deiminase 4: a transcriptional corepressor implicated in the onset and progression of rheumatoid arthritis. Biochemistry 44:10570-10582
24. Nakayama-Hamada M, Suzuki A, Kubota K, Takazawa T, Ohsaka M, Kawaida R, Ono M, Kasuya A, Furukawa H, Yamada R, Yamamoto K (2005) Comparison of enzymatic properties between hPADI2 and hPADI4. Biochem Biophys Res Commun 327:192-200
25. Bannister AJ, Kouzarides T (2005) Reversing histone methylation. Nature 436:1103-1106
26. Woods AS (2004) The mighty arginine, the stable quaternary amines, the powerful aromatics, and the aggressive phosphate: their role in the noncovalent minuet. J Proteome Res 3:478-484
27. Woods AS, Ferre S (2005) Amazing stability of the arginine-phosphate electrostatic interaction. J Proteome Res 4:1397-1402
28. van Venrooij WJ, Pruijn GJ (2000) Citrullination: a small change for a protein with great consequences for rheumatoid arthritis. Arthritis Res 2:249-251
29. György B, Tóth E, Tarcsa E, Falus A, Buzás EI (2006) Citrullination: a posttranslational modification in health and disease. Int J Biochem Cell Biol 38:1662-1677
30. Harauz G, Ishiyama N, Hill CMD, Bates IR, Libich DS, Farès C (2004) Myelin basic protein-diverse conformational states of an intrinsically unstructured protein and its roles in myelin assembly and multiple sclerosis. Micron 35:503-542
31. Boggs JM (2006) Myelin basic protein: a multifunctional protein. Cell Mol Life Sci 63 (In press)
32. Moscarello MA, Mastronardi F, Wood DD (2006) The role of citrullinated proteins suggests a novel mechanism in the pathogenesis of multiple sclerosis. Neurochem Res (This issue)
33. Curran JF (2003) Death, taxes, and the genetic code? Chem Biol 10:586-587
34. Ishiyama N, Bates IR, Hill CMD, Wood DD, Matharu P, Viner NJ, Moscarello MA, Harauz G (2001) The effects of deimination of myelin basic protein on structures formed by its interaction with phosphoinositide-containing lipid monolayers. J Struct Biol 136:30-45
35. Hill CMD, Bates IR, White GF, Hallett FR, Harauz G (2002) Effects of the osmolyte trimethylamine-N-oxide on conformation, self-association, and two-dimensional crystallization of myelin basic protein. J Struct Biol 139:13-26
36. Ishiyama N, Hill CMD, Bates IR, Harauz G (2002) The formation of helical tubular vesicles by binary monolayers containing a nickel-chelating lipid and phosphoinositides in the presence of basic polypeptides. Chem Phys Lipids 114:103-111
37. 2+-calmodulin: effects of deimination assessed by intrinsic Trp fluorescence spectroscopy, dynamic light scattering, and circular dichroism. Protein Sci 12:1507-1521
38. Polverini E, Boggs JM, Bates IR, Harauz G, Cavatorta P (2004) Electron paramagnetic resonance spectroscopy and molecular modelling of the interaction of myelin basic protein (MBP) with calmodulin (CaM)-diversity and conformational adaptability of MBP CaM-targets. J Struct Biol 148:353-369
39. Kroner PA, Friedman KD, Fahs SA, Scott JP, Montgomery RR (1991) Abnormal binding of factor VIII is linked with the substitution of glutamine for arginine 91 in von Willebrand factor in a variant form of von Willebrand disease. J Biol Chem 266:19146-19149
40. Durovic S, Mrz W, Frank S, Scharnagl H, Baumstark MW, Zechner R, Kostner GM (1994) Decreased binding of apolipoprotein (a) to familial defective apolipoprotein B-100 (Arg3500 → Gln). A study of the assembly of recombinant apolipoprotein (a) with mutant low density lipoproteins. J Biol Chem 269:30320-30325
41. Kishimoto M, Hashiramoto M, Yonezawa K, Shii K, Kazumi T, Kasuga M (1994) Substitution of glutamine for arginine 1131. A newly identified mutation in the catalytic loop of the tyrosine kinase domain of the human insulin receptor. J Biol Chem 269:11349-11355
42. Baumann N, Pham-Dinh D (2001) Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 81:871-927
43. Trapp BD, Kidd GJ (2004) Structure of the myelinated axon. In: Lazzarini RA, Griffin JW, Lassman H, Nave K-A, Miller RH, Trapp BD (eds) Myelin biology and disorders. Elsevier Academic Press, San Diego, pp 3-27
44. Pribyl TM, Campagnoni CW, Kampf K, Kashima T, Handley VW, McMahon J, Campagnoni AT (1993) The human myelin basic protein gene is included within a 179-kilobase transcription unit: expression in the immune and central nervous systems. Proc Natl Acad Sci USA 90:10695-10699
45. Campagnoni AT, Pribyl TM, Campagnoni CW, Kampf K, Amur-Umarjee S, Landry CF, Handley VW, Newman SL, Garbay B, Kitamura K (1993) Structure and developmental regulation of Golli-mbp, a 105-kilobase gene that encompasses the myelin basic protein gene and is expressed in cells in the oligodendrocyte lineage in the brain. J Biol Chem 268:4930-4938
46. Campagnoni AT, Campagnoni C (2004) Myelin basic protein gene. In: Lazzarini RA, Griffin JW, Lassman H, Nave K-A, Miller RH, Trapp BD (eds) Myelin biology and disorders. Elsevier Academic Press, San Diego, pp 387-400
47. Landry CF, Ellison JA, Pribyl TM, Campagnoni C, Kampf K, Campagnoni AT (1996) Myelin basic protein gene expression in neurons: developmental and regional changes in protein targeting within neuronal nuclei, cell bodies, and processes. J Neurosci 16:2452-2462
48. Givogri MI, Bongarzone ER, Schonmann V, Campagnoni AT (2001) Expression and regulation of golli products of myelin basic protein gene during in vitro development of oligodendrocytes. J Neurosci Res 66:679-690
49. Farhadi HF, Lepage P, Forghani R, Friedman HC, Orfali W, Jasmin L, Miller W, Hudson TJ, Peterson AC (2003) A combinatorial network of evolutionarily conserved myelin basic protein regulatory sequences confers distinct glial-specific phenotypes. J Neurosci 23:10214-10223
50. Farhadi HF, Peterson AC (2006) The myelin basic protein gene: a prototype for combinatorial mammalian transcriptional regulation. Adv Neurol 98:65-76
51. Brady GW, Murthy NS, Fein DB, Wood DD, Moscarello MA (1981) The effect of basic myelin protein on multilayer membrane formation. Biophys J 34:345-350
52. Sedzik J, Blaurock AE, Hochli M (1984) Lipid/myelin basic protein multilayers. A model for the cytoplasmic space in central nervous system myelin. J Mol Biol 174:385-409
53. Hu Y, Doudevski I, Wood DD, Moscarello MA, Husted C, Genain C, Zasadzinski JA, Israelachvili J (2004) Synergistic interactions of lipids and myelin basic protein. Proc Natl Acad Sci USA 101:13466-13471
54. Cristofolini L, Fontana MP, Serra F, Fasano A, Riccio P, Konovalov O (2005) Microstructural analysis of the effects of incorporation of myelin basic protein in phospholipid layers. Eur Biophys J 34:1041-1048
55. Bates IR, Feix JB, Boggs JM, Harauz G (2004) An immunodominant epitope of myelin basic protein is an amphipathic alpha-helix. J Biol Chem 279:5757-5764
56. Musse AA, Boggs JM, Harauz G (2006) Deimination of membrane-bound myelin basic protein in multiple sclerosis exposes an immunodominant epitope. Proc Natl Acad Sci USA 103:4422-4427
57. Bates IR, Boggs JM, Feix JB, Harauz G (2003) Membrane-anchoring and charge effects in the interaction of myelin basic protein with lipid bilayers studied by site-directed spin labeling. J Biol Chem 278:29041-29047
58. Wood DD, Moscarello MA (1997) Myelin basic protein - the implication of post-translational changes for demyelinating disease. In: Russell WC (eds) Molecular biology of multiple sclerosis. Wiley, New York, pp 37-54
59. Martenson RE, Gaitonde M (1969) Comparative studies of highly basic proteins of ox brain and rat brain. Microheterogeneity of basic encephalitogenic (myelin) protein. J Neurochem 16:889-898
60. Martenson RE, Gaitonde MK (1969) Electrophoretic analysis of the highly basic proteins of the rat brain fraction which induces experimental allergic encephalomyelitis. J Neurochem 16:333-347
61. Chou FC, Chou CH, Shapira R, Kibler RF (1976) Basis of microheterogeneity of myelin basic protein. J Biol Chem 251:2671-2679
62. Cheifetz S, Moscarello MA, Deber CM (1984) NMR investigation of the charge isomers of bovine myelin basic protein. Arch Biochem Biophys 233:151-160
63. Fannon AM, Moscarello MA (1991) Characterization of myelin basic protein charge isomers from adult mouse brain. Neuroreport 2:135-138
64. Boulias C, Pang H, Mastronardi F, Moscarello MA (1995) The isolation and characterization of four myelin basic proteins from the unbound fraction during CM52 chromatography. Arch Biochem Biophys 322:174-182
65. Wood DD, McLaurin J, Moscarello MA (1990) A hydroxyproline-containing protein from shark brain that is related to myelin basic protein. J Neurochem 55:1697-1702
66. Mastronardi FG, Boulias C, Roots BI, Moscarello MA (1993) Characterization of basic proteins from goldfish myelin. J Neurochem 60:153-160
67. Zand R, Jin X, Kim J, Wall DB, Gould R, Lubman DM (2001) Studies of posttranslational modifications in spiny dogfish myelin basic protein. Neurochem Res 26:539-547
68. Wood DD, She YM, Freer AD, Harauz G, Moscarello MA (2002) Primary structure of equine myelin basic protein by mass spectrometry. Arch Biochem Biophys 405:137-146
69. Zand R, Li MX, Jin X, Lubman D (1998) Determination of the sites of posttranslational modifications in the charge isomers of bovine myelin basic protein by capillary electrophoresis-mass spectroscopy. Biochemistry 37:2441-2449
70. Kim JK, Mastronardi FG, Wood DD, Lubman DM, Zand R, Moscarello MA (2003) Multiple sclerosis: an important role for post-translational modifications of myelin basic protein in pathogenesis. Mol Cell Proteomics 2:453-462
71. Wood DD, Moscarello MA (1989) The isolation, characterization, and lipid-aggregating properties of a citrulline containing myelin basic protein. J Biol Chem 264:5121-5127
72. Koshy KM, Boggs JM (1993) Interference of carbohydrates in the quantitation of protein-bound citrulline by amino acid analysis. Anal Biochem 208:375-381
73. Yang XJ (2005) Multisite protein modification and intramolecular signaling. Oncogene 24:1653-1662
74. Martenson RE (1980) Myelin basic protein: what does it do? In: Kumar S (eds) Biochemistry of brain. Pergamon, Oxford, pp 49-79
75. Campagnoni AT, Skoff RP (2001) The pathobiology of myelin mutants reveal novel biological functions of the MBP and PLP genes. Brain Pathol 11:74-91
76. Lassmann H (2004) Cellular damage and repair in multiple sclerosis. In: Lazzarini RA, Griffin JW, Lassman H, Nave K-A, Miller RH, Trapp BD (eds) Myelin biology and disorders. Elsevier Academic Press, San Diego, pp 733-762
77. Ferguson B, Matyszak MK, Esiri MM, Perry VH (1997) Axonal damage in acute multiple sclerosis lesions. Brain 120:393-399
78. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L (1998) Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338:278-285
79. Lutton JD, Winston R, Rodman TC (2004) Multiple sclerosis: etiological mechanisms and future directions. Exp Biol Med (Maywood) 229:12-20
80. Compston A (2004) Genetic susceptibility and epidemiology. In: Lazzarini RA, Griffin JW, Lassman H, Nave K-A, Miller RH, Trapp BD (eds) Myelin biology and disorders. Elsevier Academic Press, San Diego, pp 701-731
81. Sospedra M, Martin R (2005) Immunology of multiple sclerosis. Annu Rev Immunol 23:683-747
82. Ibrahim SM, Gold R (2005) Genomics, proteomics, metabolomics: what is in a word for multiple sclerosis? Curr Opin Neurol 18:231-235
83. Oksenberg JR, Barcellos LF (2005) Multiple sclerosis genetics: leaving no stone unturned. Genes Immun 6:375-387
84. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (1999) A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain 122:2279-2295
85. Lassmann H, Bruck W, Lucchinetti C (2001) Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol Med 7:115-121
86. Lublin FD (2004) Multiple sclerosis classification and overview. In: Lazzarini RA, Griffin JW, Lassman H, Nave K-A, Miller RH, Trapp BD (eds) Myelin biology and disorders. Elsevier Academic Press, San Diego, pp 691-699
87. John GR, Shankar SL, Shafit-Zagardo B, Massimi A, Lee SC, Raine CS, Brosnan CF (2002) Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat Med 8:1115-1121
88. Franklin RJ (2002) Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci 3:705-714
89. Makhlouf K, Imitola J, Khoury SJ (2002) Experimental autoimmune encephalomyelitis and multiple sclerosis: from bench to bedside. In: Dangond F (ed) Disorders of myelin in the central and peripheral nervous systems. Butterworth/Heinemann, Woburn, pp 155-164
90. Barnett MH, Prineas JW (2004) Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 55:458-468
91. Chaudhuri A, Behan PO (2005) Multiple sclerosis: looking beyond autoimmunity. J R Soc Med 98:303-306
92. Simons-Johnson R, Roder JC, Riordan JR (1995) Overexpression of the DM-20 myelin proteolipid causes central nervous system demyelination in transgenic mice. J Neurochem 64:967-976
93. Mastronardi FG, Ackerley CA, Arsenault L, Roots BI, Moscarello MA (1993) Demyelination in a transgenic mouse: a model for multiple sclerosis. J Neurosci Res 36:315-324
94. Barrese N, Mak B, Fisher L, Moscarello MA (1998) Mechanism of demyelination in DM20 transgenic mice involves increased fatty acylation. J Neurosci Res 53:143-152
95. Mastronardi FG, Al Sabbagh A, Nelson PA, Rego J, Roots BI, Moscarello MA (1996) Myelin basic protein in experimental allergic encephalomyelitis is not affected at the posttranslational level: implications for demyelinating disease. J Neurosci Res 44:344-349
96. Mastronardi FG, Ackerley CA, Roots BI, Moscarello MA (1996) Loss of myelin basic protein cationicity in DM20 transgenic mice is dosage dependent. J Neurosci Res 44:301-307
97. Mastronardi FG, Mak B, Ackerley CA, Roots BI, Moscarello MA (1996) Modifications of myelin basic protein in DM20 transgenic mice are similar to those in myelin basic protein from multiple sclerosis. J Clin Invest 97:349-358
98. Moscarello MA (1997) Myelin basic protein, the "executive" molecule of the myelin membrane. In: Juurlink BHJ, Devon RM, Doucette JR, Nazarali AJ, Schreyer DJ, Verge VMK (eds) Cell biology and pathology of myelin: evolving biological concepts and therapeutic approaches. Plenum Press, New York, pp 13-25
99. Finch PR, Wood DD, Moscarello MA (1971) The presence of citrulline in a myelin protein fraction. FEBS Lett 15:145-148
100. Moscarello MA, Wood DD, Ackerley C, Boulias C (1994) Myelin in multiple sclerosis is developmentally immature. J Clin Invest 94:146-154
101. Wood DD, Bilbao JM, O'Connors P, Moscarello MA (1996) Acute multiple sclerosis (Marburg type) is associated with developmentally immature myelin basic protein. Ann Neurol 40:18-24
102. Whitaker JN, Mitchell GW (1996) A possible role for altered myelin basic protein in multiple sclerosis. Ann Neurol 40:3-4
103. Wood DD, Moscarello MA (1984) Is the myelin membrane abnormal in multiple sclerosis? J Membr Biol 79:195-201
104. Martin R, Whitaker JN, Rhame L, Goodin RR, McFarland HF (1994) Citrulline-containing myelin basic protein is recognized by T-cell lines derived from multiple sclerosis patients and healthy individuals. Neurology 44:123-129
105. Tranquill LR, Cao L, Ling NC, Kalbacher H, Martin RM, Whitaker JN (2000) Enhanced T cell responsiveness to citrulline-containing myelin basic protein in multiple sclerosis patients. Mult Scler 6:220-225
106. Ursell MR, McLaurin J, Wood DD, Ackerley CA, Moscarello MA (1995) Localization and partial characterization of a 60 kDa citrulline-containing transport form of myelin basic protein from MO3-13 cells and human white matter. J Neurosci Res 42:41-53
107. Fannon AM, Moscarello MA (1990) Myelin basic protein is affected by reduced synthesis of myelin proteolipid protein in the jimpy mouse. Biochem J 268:105-110
108. Akiyama K, Sakurai Y, Asou H, Senshu T (1999) Localization of peptidylarginine deiminase type II in a stage-specific immature oligodendrocyte from rat cerebral hemisphere. Neurosci Lett 274:53-55
109. Seiwa C, Sugiyama I, Yagi T, Iguchi T, Asou H (2000) Fyn tyrosine kinase participates in the compact myelin sheath formation in the central nervous system. Neurosci Res 37:21-31
110. Sambandam T, Belousova M, Accaviti-Loper MA, Blanquicett C, Guercello V, Raijmakers R, Nicholas AP (2004) Increased peptidylarginine deiminase type II in hypoxic astrocytes. Biochem Biophys Res Commun 325:1324-1329
111. Nicholas AP, Sambandam T, Echols JD, Barnum SR (2005) Expression of citrullinated proteins in murine experimental autoimmune encephalomyelitis. J Comp Neurol 486:254-266
112. Raijmakers R, Vogelzangs J, Croxford JL, Wesseling P, van Venrooij WJ, Pruijn GJ (2005) Citrullination of central nervous system proteins during the development of experimental autoimmune encephalomyelitis. J Comp Neurol 486:243-253
113. Ishigami A, Ohsawa T, Hiratsuka M, Taguchi H, Kobayashi S, Saito Y, Murayama S, Asaga H, Toda T, Kimura N, Maruyama N (2005) Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease. J Neurosci Res 80:120-128
114. Bhattacharya SK, Crabb JS, Bonilha VL, Gu X, Takahara H, Crabb JW (2006) Proteomics implicates peptidyl arginine deiminase 2 and optic nerve citrullination in glaucoma pathogenesis. Invest Ophthalmol Vis Sci 47:2508-2514
115. Nicholas AP, Sambandam T, Echols JD, Tourtellotte WW (2004) Increased citrullinated glial fibrillary acidic protein in secondary progressive multiple sclerosis. J Comp Neurol 473:128-136
116. Kubilus J, Baden HP (1983) Purification and properties of a brain enzyme which deiminates proteins. Biochim Biophys Acta 745:285-291
117. Takahara H, Koyama M, Sugawara K (1987) Subcellular location of peptidylarginine deiminase in the mouse brain. Agric Biol Chem 51:1471-1473
118. Vincent SR, Leung E, Watanabe K (1992) Immunohistochemical localization of peptidylarginine deiminase in the rat brain. J Chem Neuroanat 5:159-168
119. Lamensa JW, Moscarello MA (1993) Deimination of human myelin basic protein by a peptidylarginine deiminase from bovine brain. J Neurochem 61:987-996
120. Pritzker LB, Nguyen TA, Moscarello MA (1999) The developmental expression and activity of peptidylarginine deiminase in the mouse. Neurosci Lett 266:161-164
121. Moscarello MA, Pritzker L, Mastronardi FG, Wood DD (2002) Peptidylarginine deiminase: a candidate factor in demyelinating disease. J Neurochem 81:335-343
122. Mastronardi FG, Moscarello MA (2005) Molecules affecting myelin stability: a novel hypothesis regarding the pathogenesis of multiple sclerosis. J Neurosci Res 80:301-308
123. Mastronardi FG, Wood DD, Mei J, Raijmakers R, Tseveleki V, Dosch H-M, Probert L, Casaccia-Bonnefil P, Moscarello MA (2006) Increased citrullination of histone H3 in MS brain and animal models for demyelination: A role for TNF-induced PAD4 translocation. J Neurosci (Submitted)
124. De Keyser J, Schaaf M, Teelken A (1999) Peptidylarginine deiminase activity in postmortem white matter of patients with multiple sclerosis. Neurosci Lett 260:74-76
125. Takahara H, Oikawa Y, Sugawara K (1983) Purification and characterization of peptidylarginine deiminase from rabbit skeletal muscle. J Biochem (Tokyo) 94:1945-1953
126. Watanabe K, Akiyama K, Hikichi K, Ohtsuka R, Okuyama A, Senshu T (1988) Combined biochemical and immunochemical comparison of peptidylarginine deiminases present in various tissues. Biochim Biophys Acta 966:375-383
127. Nomura K (1992) Specificity and mode of action of the muscle-type protein-arginine deiminase. Arch Biochem Biophys 293:362-369
128. Senshu T, Kan S, Ogawa H, Manabe M, Asaga H (1996) Preferential deimination of keratin K1 and filaggrin during the terminal differentiation of human epidermis. Biochem Biophys Res Commun 225:712-719
129. Tarcsa E, Marekov LN, Mei G, Melino G, Lee SC, Steinert PM (1996) Protein unfolding by peptidylarginine deiminase. Substrate specificity and structural relationships of the natural substrates trichohyalin and filaggrin. J Biol Chem 271:30709-30716
130. Tarcsa E, Marekov LN, Andreoli J, Idler WW, Candi E, Chung SI, Steinert PM (1997) The fate of trichohyalin. Sequential post-translational modifications by peptidylarginine deiminase and transglutaminases. J Biol Chem 272:27893-27901
131. Mizoguchi M, Manabe M, Kawamura Y, Kondo Y, Ishidoh K, Kominami E, Watanabe K, Asaga H, Senshu T, Ogawa H (1998) Deimination of 70-kD nuclear protein during epidermal apoptotic events in vitro. J Histochem Cytochem 46:1303-1309
132. Takai Y, Ogawara M, Tomono Y, Moritoh C, Imajoh-Ohmi S, Tsutsumi O, Taketani Y, Inagaki M (1996) Mitosis-specific phosphorylation of vimentin by protein kinase C coupled with reorganization of intracellular membranes. J Cell Biol 133:141-149
133. Asaga H, Yamada M, Senshu T (1998) Selective deimination of vimentin in calcium ionophore-induced apoptosis of mouse peritoneal macrophages. Biochem Biophys Res Commun 243:641-646
134. Vossenaar ER, Zendman AJ, van Venrooij WJ (2004) Citrullination, a possible functional link between susceptibility genes and rheumatoid arthritis. Arthritis Res Ther 6:1-5
135. Lundberg K, Nijenhuis S, Vossenaar ER, Palmblad K, van Venrooij WJ, Klareskog L, Zendman AJ, Harris HE (2005) Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity. Arthritis Res Ther 7:R458-R467
136. Vossenaar ER, Robinson WH (2005) Citrullination and autoimmune disease: 8th Bertine Koperberg meeting. Ann Rheum Dis 64:1513-1515
137. Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ (1998) Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 101:273-281
138. Girbal-Neuhauser E, Durieux JJ, Arnaud M, Dalbon P, Sebbag M, Vincent C, Simon M, Senshu T, Masson-Bessière C, Jolivet-Reynaud C, Jolivet M, Serre G (1999) The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol 162:585-594
139. Masson-Bessière C, Sebbag M, Girbal-Neuhauser E, Nogueira L, Vincent C, Senshu T, Serre G (2001) The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J Immunol 166:4177-4184
140. Hill J, Cairns E, Bell DA (2004) The joy of citrulline: new insights into the diagnosis, pathogenesis, and treatment of rheumatoid arthritis. J Rheumatol 31:1471-1473
141. Nijenhuis S, Zendman AJ, Vossenaar ER, Pruijn GJ, van Venrooij WJ (2004) Autoantibodies to citrullinated proteins in rheumatoid arthritis: clinical performance and biochemical aspects of an RA-specific marker. Clin Chim Acta 350:17-34
142. Vossenaar ER, Despres N, Lapointe E, van der HA, Lora M, Senshu T, van Venrooij WJ, Menard HA (2004) Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin. Arthritis Res Ther 6:R142-R150
143. Vossenaar ER, van Venrooij WJ (2004) Citrullinated proteins: sparks that may ignite the fire in rheumatoid arthritis. Arthritis Res Ther 6:107-111
144. Zendman AJ, Vossenaar ER, van Venrooij WJ (2004) Autoantibodies to citrullinated (poly)peptides: a key diagnostic and prognostic marker for rheumatoid arthritis. Autoimmunity 37:295-299
145. Yamada R (2005) Peptidylarginine deiminase type 4, anticitrullinated peptide antibodies, and rheumatoid arthritis. Autoimmun Rev 4:201-206
146. Migliorini P, Pratesi F, Tommasi C, Anzilotti C (2005) The immune response to citrullinated antigens in autoimmune diseases. Autoimmun Rev 4:561-564
147. Yamada R, Suzuki A, Chang X, Yamamoto K (2003) Peptidylarginine deiminase type 4: identification of a rheumatoid arthritis-susceptible gene. Trends Mol Med 9:503-508
148. Suzuki A, Yamada R, Chang X, Tokuhiro S, Sawada T, Suzuki M, Nagasaki M, Nakayama-Hamada M, Kawaida R, Ono M, Ohtsuki M, Furukawa H, Yoshino S, Yukioka M, Tohma S, Matsubara T, Wakitani S, Teshima R, Nishioka Y, Sekine A, Iida A, Takahashi A, Tsunoda T, Nakamura Y, Yamamoto K (2003) Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 34:395-402
149. Chang X, Yamada R, Sawada T, Suzuki A, Kochi Y, Yamamoto K (2005) The inhibition of antithrombin by peptidylarginine deiminase 4 may contribute to pathogenesis of rheumatoid arthritis. Rheumatology (Oxford) 44:293-298
150. Chang X, Yamada R, Suzuki A, Sawada T, Yoshino S, Tokuhiro S, Yamamoto K (2005) Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis. Rheumatology (Oxford) 44:40-50
151. Stone EM, Schaller TH, Bianchi H, Person MD, Fast W (2005) Inactivation of two diverse enzymes in the amidinotransferase superfamily by 2-chloroacetamidine: dimethylargininase and peptidylarginine deiminase. Biochemistry 44:13744-13752
152. Luo Y, Knuckley B, Lee YH, Stallcup MR, Thompson PR (2006) A fluoroacetamidine-based inactivator of protein arginine deiminase 4: design, synthesis, and in vitro and in vivo evaluation. J Am Chem Soc 128:1092-1093
153. Doyle HA, Mamula MJ (2001) Post-translational protein modifications in antigen recognition and autoimmunity. Trends Immunol 22:443-449
154. Doyle HA, Mamula MJ (2002) Posttranslational protein modifications: new flavors in the menu of autoantigens. Curr Opin Rheumatol 14:244-249
155. Doyle HA, Mamula MJ (2005) Posttranslational modifications of self-antigens. Ann N Y Acad Sci 1050:1-9
156. Moscarello MA (1990) Myelin basic protein: a dynamically changing structure. Prog Clin Biol Res 336:25-48
157. Wright PE, Dyson HJ (1999) Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. J Mol Biol 293:321-331
158. Uversky VN, Gillespie JR, Fink AL (2000) Why are "natively unfolded" proteins unstructured under physiologic conditions? Proteins 41:415-427
159. Dunker AK, Brown CJ, Lawson JD, Iakoucheva LM, Obradovic Z (2002) Intrinsic disorder and protein function. Biochemistry 41:6573-6582
160. Fink AL (2005) Natively unfolded proteins. Curr Opin Struct Biol 15:35-41
161. Receveur-Bréchot V, Bourhis JM, Uversky VN, Canard B, Longhi S (2006) Assessing protein disorder and induced folding. Proteins 62:24-45
162. Ward JJ, Sodhi JS, McGuffin LJ, Buxton BF, Jones DT (2004) Prediction and functional analysis of native disorder in proteins from the three kingdoms of life. J Mol Biol 337:635-645
163. Tompa P (2002) Intrinsically unstructured proteins. Trends Biochem Sci 27:527-533
164. Tompa P, Szasz C, Buday L (2005) Structural disorder throws new light on moonlighting. Trends Biochem Sci 30:484-489
165. Tompa P (2005) The interplay between structure and function in intrinsically unstructured proteins. FEBS Lett 579:3346-3354
166. Dunker AK, Cortese MS, Romero P, Iakoucheva LM, Uversky VN (2005) Flexible nets. The roles of intrinsic disorder in protein interaction networks. FEBS J 272:5129-5148
167. Patil A, Nakamura H (2006) Disordered domains and high surface charge confer hubs with the ability to interact with multiple proteins in interaction networks. FEBS Lett 580:2041-2045
168. Shoemaker BA, Portman JJ, Wolynes PG (2000) Speeding molecular recognition by using the folding funnel: the fly-casting mechanism. Proc Natl Acad Sci USA 97:8868-8873
169. Gunasekaran K, Tsai CJ, Kumar S, Zanuy D, Nussinov R (2003) Extended disordered proteins: targeting function with less scaffold. Trends Biochem Sci 28:81-85
170. Fuxreiter M, Simon I, Friedrich P, Tompa P (2004) Pre-formed structural elements feature in partner recognition by intrinsically unstructured proteins. J Mol Biol 338:1015-1026
171. Oldfield CJ, Cheng Y, Cortese MS, Romero P, Uversky VN, Dunker AK (2005) Coupled folding and binding with alpha-helix-forming molecular recognition elements. Biochemistry 44:12454-12470
172. Dyson HJ, Wright PE (2002) Coupling of folding and binding for unstructured proteins. Curr Opin Struct Biol 12:54-60
173. Cao L, Goodin R, Wood D, Moscarello MA, Whitaker JN (1999) Rapid release and unusual stability of immunodominant peptide 45-89 from citrullinated myelin basic protein. Biochemistry 38:6157-6163
174. Beniac DR, Wood DD, Palaniyar N, Ottensmeyer FP, Moscarello MA, Harauz G (1999) Marburg's variant of multiple sclerosis correlates with a less compact structure of myelin basic protein. Mol Cell Biol Res Commun 1:48-51
175. Pritzker LB, Joshi S, Gowan JJ, Harauz G, Moscarello MA (2000) Deimination of myelin basic protein. 1. Effect of deimination of arginyl residues of myelin basic protein on its structure and susceptibility to digestion by cathepsin D. Biochemistry 39:5374-5381
176. Pritzker LB, Joshi S, Harauz G, Moscarello MA (2000) Deimination of myelin basic protein. 2. Effect of methylation of MBP on its deimination by peptidylarginine deiminase. Biochemistry 39:5382-5388
177. D'Souza CA, Wood DD, She YM, Moscarello MA (2005) Autocatalytic cleavage of myelin basic protein: an alternative to molecular mimicry. Biochemistry 44:12905-12913
178. Moscarello MA, Pang H, Pace-Asciak CR, Wood DD (1992) The N-terminus of human myelin basic protein consists of C2, C4, C6, and C8 alkyl carboxylic acids. J Biol Chem 267:9779-9782
179. Boulias C, Moscarello MA (1994) ADP-ribosylation of human myelin basic protein. J Neurochem 63:351-359
180. Bates IR, Matharu P, Ishiyama N, Rochon D, Wood DD, Polverini E, Moscarello MA, Viner NJ, Harauz G (2000) Characterization of a recombinant murine 18.5-kDa myelin basic protein. Protein Expr Purif 20:285-299
181. Brady GW, Fein DB, Wood DD, Moscarello MA (1981) The interaction of basic proteins from normal and multiple sclerosis myelin with phosphatidylglycerol vesicles. FEBS Lett 125:159-160
182. Brady GW, Fein DB, Wood DD, Moscarello MA (1985) The role of charge microheterogeneity of human myelin basic protein in the formation of phosphatidylglycerol multilayers. Biochem Biophys Res Commun 126:1161-1165
183. Cheifetz S, Boggs JM, Moscarello MA (1985) Increase in vesicle permeability mediated by myelin basic protein: effect of phosphorylation of basic protein. Biochemistry 24:5170-5175
184. Cheifetz S, Moscarello MA (1985) Effect of bovine basic protein charge microheterogeneity on protein-induced aggregation of unilamellar vesicles containing a mixture of acidic and neutral phospholipids. Biochemistry 24:1909-1914
185. Moscarello MA, Chia LS, Leighton D, Absolom D (1985) Size and surface charge properties of myelin vesicles from normal and diseased (multiple sclerosis) brain. J Neurochem 45:415-421
186. Deber CM, Hughes DW, Fraser PE, Pawagi AB, Moscarello MA (1986) Binding of human normal and multiple sclerosis-derived myelin basic protein to phospholipid vesicles: effects on membrane head group and bilayer regions. Arch Biochem Biophys 245:455-463
187. Moscarello MA, Brady GW, Fein DB, Wood DD, Cruz TF (1986) The role of charge microheterogeneity of basic protein in the formation and maintenance of the multilayered structure of myelin: a possible role in multiple sclerosis. J Neurosci Res 15:87-99
188. Jo E, Boggs JM (1995) Aggregation of acidic lipid vesicles by myelin basic protein: dependence on potassium concentration. Biochemistry 34:13705-13716
189. Boggs JM, Yip PM, Rangaraj G, Jo E (1997) Effect of posttranslational modifications to myelin basic protein on its ability to aggregate acidic lipid vesicles. Biochemistry 36:5065-5071
190. MacMillan SV, Ishiyama N, White GF, Palaniyar N, Hallett FR, Harauz G (2000) Myelin basic protein component C1 in increasing concentrations can elicit fusion, aggregation, and fragmentation of myelin-like membranes. Eur J Cell Biol 79:327-335
191. Boggs JM, Rangaraj G, Koshy KM, Ackerley C, Wood DD, Moscarello MA (1999) Highly deiminated isoform of myelin basic protein from multiple sclerosis brain causes fragmentation of lipid vesicles. J Neurosci Res 57:529-535
192. McLaurin J, Ackerley CA, Moscarello MA (1993) Localization of basic proteins in human myelin. J Neurosci Res 35:618-628
193. Beniac DR, Wood DD, Palaniyar N, Ottensmeyer FP, Moscarello MA, Harauz G (2000) Cryoelectron microscopy of protein-lipid complexes of human myelin basic protein charge isomers differing in degree of citrullination. J Struct Biol 129:80-95
194. Tompkins TA, Moscarello MA (1993) Stimulation of bovine brain phospholipase C activity by myelin basic protein requires arginyl residues in peptide linkage. Arch Biochem Biophys 302:476-483
195. Libich DS, Hill CMD, Haines JD, Harauz G (2003) Myelin basic protein has multiple calmodulin-binding sites. Biochem Biophys Res Commun 308:313-319
196. Boggs JM, Rangaraj G, Hill CM, Bates IR, Heng YM, Harauz G (2005) Effect of arginine loss in myelin basic protein, as occurs in its deiminated charge isoform, on mediation of actin polymerization and actin binding to a lipid membrane in vitro. Biochemistry 44:3524-3534
197. Hill CMD, Libich DS, Harauz G (2005) Assembly of tubulin by classic myelin basic protein isoforms and regulation by post-translational modification. Biochemistry 44:16672-16683
198. Shanshiashvili LV, Suknidze NC, Machaidze GG, Mikeladze DG, Ramsden JJ (2003) Adhesion and clustering of charge isomers of myelin basic protein at model myelin membranes. Arch Biochem Biophys 419:170-177
199. DeBruin LS, Haines JD, Wellhauser LA, Radeva G, Schonmann V, Bienzle D, Harauz G (2005) Developmental partitioning of myelin basic protein into membrane microdomains. J Neurosci Res 80:211-225
200. DeBruin LS, Harauz G (2006) White matter rafting - membrane microdomains in myelin. Neurochem Res (This issue)
201. Polverini E, Fasano A, Zito F, Riccio P, Cavatorta P (1999) Conformation of bovine myelin basic protein purified with bound lipids. Eur Biophys J 28:351-355
202. Farès C, Libich DS, Harauz G (2006) Solution NMR structure of an immunodominant epitope of myelin basic protein. FEBS J 273:601-614
203. Cuzner ML, Davison AN (1973) Changes in cerebral lysosomal enzyme activity and lipids in multiple sclerosis. J Neurol Sci 19:29-36
204. Cavatorta P, Giovanelli S, Bobba A, Riccio P, Quagliariello E (1991) Interaction of cations with lipid-free myelin basic protein. A spectroscopy study. Acta Neurol (Napoli) 13:162-169
205. Berlet HH, Bischoff H, Weinhardt F (1994) Divalent metals of myelin and their differential binding bymyelin basic protein of bovine central nervous system. Neurosci Lett 179:75-78
206. Earl C, Chantry A, Mohammad N, Glynn P (1988) Zinc ions stabilise the association of basic protein with brain myelin membranes. J Neurochem 51:718-724
207. Cavatorta P, Giovanelli S, Bobba A, Riccio P, Szabo AG, Quagliariello E (1994) Myelin basic protein interaction with zinc and phosphate: fluorescence studies on the water-soluble form of the protein. Biophys J 66:1174-1179
208. Riccio P, Giovannelli S, Bobba A, Romito E, Fasano A, Bleve-Zacheo T, Favilla R, Quagliariello E, Cavatorta P (1995) Specificity of zinc binding to myelin basic protein. Neurochem Res 20:1107-1113
209. Tsang D, Tsang YS, Ho WK, Wong RN (1997) Myelin basic protein is a zinc-binding protein in brain: possible role in myelin compaction. Neurochem Res 22:811-819
210. Ho SY, Catalanotto FA, Lisak RP, Dore-Duffy P (1986) Zinc in multiple sclerosis. II: correlation with disease activity and elevated plasma membrane-bound zinc in erythrocytes from patients with multiple sclerosis. Ann Neurol 20:712-715
211. Berlet HH, Ilzenhofer H, Gass P (1991) Restricted endogenous proteolysis of myelin basic protein of zinc-treated myelin. Acta Neurol (Napoli) 13:145-152
212. Nuzzo S, Meneghini C, Mobilioo S, Haas H, Riccio P, Fasano A, Cavatorta P, Morante S (2002) An x-ray absorption spectroscopy study of the zinc environment in Langmuir-Blodgett phospholipid multilayers. Biophys J 83:3507-3512
213. McLaurin J, Moscarello MA (1990) The preparation of antibodies reactive against citrulline-containing charge isomers of myelin basic protein but not against the arginine-containing charge isomers. Anal Biochem 191:272-277
214. McLaurin J, Hashim G, Moscarello MA (1992) An antibody specific for component 8 of myelin basic protein from normal brain reacts strongly with component 8 from multiple sclerosis brain. J Neurochem 59:1414-1420
215. Cruz TF, Moscarello MA (1985) Characterization of myelin fractions from human brain white matter. J Neurochem 44:1411-1418
216. Husted C (2006) Structural insight into the role of myelin basic protein in multiple sclerosis. Proc Natl Acad Sci USA 103:4339-4340
217. Matsuo A, Lee GC, Terai K, Takami K, Hickey WF, McGeer EG, McGeer PL (1997) Unmasking of an unusual myelin basic protein epitope during the process of myelin degeneration in humans: a potential mechanism for the generation of autoantigens. Am J Pathol 150:1253-1266
218. Liuzzi GM, Tamborra R, Ventola A, Bisaccia F, Quagliariello E, Riccio P (1996) Different recognition by clostripain of myelin basic protein in the lipid-free and lipid-bound forms. Biochem Biophys Res Commun 226:566-571
219. Medveczky P, Antal J, Patthy A, Kekesi K, Juhasz G, Szilagyi L, Graf L (2006) Myelin basic protein, an autoantigen in multiple sclerosis, is selectively processed by human trypsin 4. FEBS Lett 580:545-552
220. Napolitano L, Lebaron F, Scaletti J (1967) Preservation of myelin lamellar structure in the absence of lipid. A correlated chemical and morphological study. J Cell Biol 34:817-826
221. Tompkins TA, Moscarello MA (1994) The mechanism of stimulation of brain phospholipase C-alpha by myelin basic protein involves specific interactions. Biochim Biophys Acta 1206:208-214
222. Hill CMD, Harauz G (2005) Charge effects modulate actin assembly by classic myelin basic protein isoforms. Biochem Biophys Res Commun 329:362-369
223. Jantz D, Berg JM (2003) Expanding the DNA-recognition repertoire for zinc finger proteins beyond 20 amino acids. J Am Chem Soc 125:4960-4961
224. Martin BL, Luo S, Kintanar A, Chen M, Graves DJ (1998) Effect of citrulline for arginine replacement on the structure and turnover of phosphopeptide substrates of protein phosphatase-1. Arch Biochem Biophys 359:179-191
225. Imparl JM, Senshu T, Graves DJ (1995) Studies of calcineurin-calmodulin interaction: probing the role of arginine residues using peptidylarginine deiminase. Arch Biochem Biophys 318:370-377
226. Luo S, Martin BL, Senshu T, Graves DJ (1995) Enzymatic deimination of glycogen phosphorylase and a peptide of the phosphorylation site: identification of modification and roles in phosphorylation and activity. Arch Biochem Biophys 318:362-369
227. Eronina TB, Livanova NB, Chebotareva NA, Kurganov BI, Luo S, Graves DJ (1996) Deimination of glycogen phosphorylase b by peptidylarginine deiminase. Influence on the kinetical characteristics and dimer-tetramer transition. Biochimie 78:253-258
228. Bartleson C, Luo S, Graves DJ, Martin BL (2000) Arginine to citrulline replacement in substrates of phosphorylase kinase. Biochim Biophys Acta 1480:23-28
229. Edwards AM, Ross NW, Ulmer JB, Braun PE (1989) Interaction of myelin basic protein and proteolipid protein. J Neurosci Res 22:97-102
230. Tompkins TA, Moscarello MA (1991) A 57-kDa phosphatidylinositol-specific phospholipase C from bovine brain. J Biol Chem 266:4228-4236
231. Boggs JM, Rangaraj G (2000) Interaction of lipid-bound myelin basic protein with actin filaments and calmodulin. Biochemistry 39:7799-7806
232. Boggs JM, Rangaraj G, Gao W, Heng YM (2006) Effect of phosphorylation of myelin basic protein by MAPK on its interactions with actin and actin binding to a lipid membrane in vitro. Biochemistry 45:391-401
233. Dyer CA, Benjamins JA (1989) Organization of oligodendroglial membrane sheets: II. Galactocerebroside:antibody interactions signal changes in cytoskeleton and myelin basic protein. J Neurosci Res 24:212-221
234. Galiano MR, Andrieux A, Deloulme JC, Bosc C, Schweitzer A, Job D, Hallak ME (2006) Myelin basic protein functions as a microtubule stabilizing protein in differentiated oligodendrocytes. J Neurosci Res 84(In press)
235. Kies MW, Thompson EB, Alvord EC Jr (1965) The relationship of myelin proteins to experimental allergic encephalomyelitis. Ann N Y Acad Sci 122:148-160
236. Whitaker JN (1998) Myelin basic protein in cerebrospinal fluid and other body fluids. Mult Scler 4:16-21
237. Panitch HS, Hooper CJ, Johnson KP (1980) CSF antibody to myelin basic protein. Measurement in patients with multiple sclerosis and subacute sclerosing panencephalitis. Arch Neurol 37:206-209
238. Warren KG, Catz I, McPherson TA (1983) CSF myelin basic protein levels in acute optic neuritis and multiple sclerosis. Can J Neurol Sci 10:235-238
239. Warren KG, Catz I (1987) A correlation between cerebrospinal fluid myelin basic protein and anti-myelin basic protein in multiple sclerosis patients. Ann Neurol 21:183-189
240. Warren KG, Catz I (1993) Autoantibodies to myelin basic protein within multiple sclerosis central nervous system tissue. J Neurol Sci 115:169-176
241. Warren KG, Catz I, Johnson E, Mielke B (1994) Antimyelin basic protein and anti-proteolipid protein specific forms of multiple sclerosis. Ann Neurol 35:280-289
242. Warren KG, Catz I (1999) An extensive search for autoantibodies to myelin basic protein in cerebrospinal fluid of non-multiple-sclerosis patients: implications for the pathogenesis of multiple sclerosis. Eur Neurol 42:95-104
243. Warren KG, Catz I (2000) Kinetic profiles of cerebrospinal fluid anti-MBP in response to intravenous MBP synthetic peptide DENP(85)VVHFFKNIVTP(96)RT in multiple sclerosis patients. Mult Scler 6:300-311
244. Mouzaki A, Tselios T, Papathanassopoulos P, Matsoukas I, Chatzantoni K (2004) Immunotherapy for multiple sclerosis: basic insights for new clinical strategies. Curr Neurovasc Res 1:325-340
245. Tzakos AG, Troganis A, Theodorou V, Tselios T, Svarnas C, Matsoukas J, Apostolopoulos V, Gerothanassis IP (2005) Structure and function of the myelin proteins: current status and perspectives in relation to multiple sclerosis. Curr Med Chem 12:1569-1587
246. Mantzourani ED, Mavromoustakos TM, Platts JA, Matsoukas JM, Tselios TV (2005) Structural requirements for binding of myelin basic protein (MBP) peptides to MHC II: effects on immune regulation. Curr Med Chem 12:1521-1535
247. Nicholas AP, Whitaker JN (2002) Preparation of a monoclonal antibody to citrullinated epitopes: its characterization and some applications to immunohistochemistry in human brain. Glia 37:328-336
248. Nicholas AP, King JL, Sambandam T, Echols JD, Gupta KB, McInnis C, Whitaker JN (2003) Immunohistochemical localization of citrullinated proteins in adult rat brain. J Comp Neurol 459:251-266
249. Senshu T, Akiyama K, Ishigami A, Nomura K (1999) Studies on specificity of peptidylarginine deiminase reactions using an immunochemical probe that recognizes an enzymatically deiminated partial sequence of mouse keratin K1. J Dermatol Sci 21:113-126
250. Schlagel LJ, Bors L, Mitchell GW, King JL, Cao L, Kirk M, Whitaker JN (1997) Immunological effects of an arginine side chain contaminating synthetically prepared peptides. Mol Immunol 34:185-194
251. Zhou SR, Moscarello MA, Whitaker JN (1995) The effects of citrullination or variable amino-terminus acylation on the encephalitogenicity of human myelin basic protein in the PL/J mouse. J Neuroimmunol 62:147-152
252. Whitaker JN, Kirk KA, Herman PK, Zhou SR, Goodin RR, Moscarello MA, Wood DD (1992) An immunochemical comparison of human myelin basic protein and its modified, citrullinated form, C8. J Neuroimmunol 36:135-146
253. Zhou SR, Whitaker JN, Wood DD, Moscarello MA (1993) Immunological analysis of the amino terminal and the C8 isomer of human myelin basic protein. J Neuroimmunol 46:91-96
254. Cao L, Sun D, Whitaker JN (1998) Citrullinated myelin basic protein induces experimental autoimmune encephalomyelitis in Lewis rats through a diverse T cell repertoire. J Neuroimmunol 88:21-29
255. de Seze J, Dubucquoi S, Lefranc D, Virecoulon F, Nuez I, Dutoit V, Vermersch P, Prin L (2001) IgG reactivity against citrullinated myelin basic protein in multiple sclerosis. J Neuroimmunol 117:149-155
256. Rajendran L, Simons K (2005) Lipid rafts and membrane dynamics. J Cell Sci 118:1099-1102
257. Luger K, Mader AW, Richmond RK, Sargent DF, Richmond TJ (1997) Crystal structure of the nucleosome core particle at 2.8 Å resolution. Nature 389:251-260
258. Hansen JC, Lu X, Ross ED, Woody RW (2006) Intrinsic protein disorder, amino acid composition, and histone terminal domains. J Biol Chem 281:1853-1856
259. Pokholok DK, Harbison CT, Levine S, Cole M, Hannett NM, Lee TI, Bell GW, Walker K, Rolfe PA, Herbolsheimer E, Zeitlinger J, Lewitter F, Gifford DK, Young RA (2005) Genome-wide map of nucleosome acetylation and methylation in yeast. Cell 122:517-527
260. Thomas CE, Kelleher NL, Mizzen CA (2006) Mass spectrometric characterization of human histone H3: a bird's eye view. J Proteome Res 5:240-247
261. Margueron R, Trojer P, Reinberg D (2005) The key to development: interpreting the histone code? Curr Opin Genet Dev 15:163-176
262. Trojer P, Reinberg D (2006) Histone lysine demethylases and their impact on epigenetics. Cell 125:213-217
263. Nakashima K, Hagiwara T, Yamada M (2002) Nuclear localization of peptidylarginine deiminase V and histone deimination in granulocytes. J Biol Chem 277:49562-49568
264. Hagiwara T, Nakashima K, Hirano H, Senshu T, Yamada M (2002) Deimination of arginine residues in nucleophosmin/B23 and histones in HL-60 granulocytes. Biochem Biophys Res Commun 290:979-983
265. Wright PW, Bolling LC, Calvert ME, Sarmento OF, Berkeley EV, Shea MC, Hao Z, Jayes FC, Bush LA, Shetty J, Shore AN, Reddi PP, Tung KS, Samy E, Allietta MM, Sherman NE, Herr JC, Coonrod SA (2003) ePAD, an oocyte and early embryo-abundant peptidylarginine deiminase-like protein that localizes to egg cytoplasmic sheets. Dev Biol 256:73-88
266. Sarmento OF, Digilio LC, Wang Y, Perlin J, Herr JC, Allis CD, Coonrod SA (2004) Dynamic alterations of specific histone modifications during early murine development. J Cell Sci 117:4449-4459
267. Hagiwara T, Hidaka Y, Yamada M (2005) Deimination of histone H2A and H4 at arginine 3 in HL-60 granulocytes. Biochemistry 44:5827-5834
268. Cuthbert GL, Daujat S, Snowden AW, Erdjument-Bromage H, Hagiwara T, Yamada M, Schneider R, Gregory PD, Tempst P, Bannister AJ, Kouzarides T (2004) Histone deimination antagonizes arginine methylation. Cell 118:545-553
269. Wang Y, Wysocka J, Sayegh J, Lee YH, Perlin JR, Leonelli L, Sonbuchner LS, McDonald CH, Cook RG, Dou Y, Roeder RG, Clarke S, Stallcup MR, Allis CD, Coonrod SA (2004) Human PAD4 regulates histone arginine methylation levels via demethylimination. Science 306:279-283
270. Hidaka Y, Hagiwara T, Yamada M (2005) Methylation of the guanidino group of arginine residues prevents citrullination by peptidylarginine deiminase IV. FEBS Lett 579:4088-4092
271. Denman RB (2005) PAD: the smoking gun behind arginine methylation signaling? Bioessays 27:242-246
272. Wysocka J, Allis CD, Coonrod S (2006) Histone arginine methylation and its dynamic regulation. Front Biosci 11:344-355
273. Bannister AJ, Schneider R, Kouzarides T (2002) Histone methylation: dynamic or static? Cell 109:801-806
274. Fackelmayer FO (2005) Protein arginine methyltransferases: guardians of the Arg? Trends Biochem Sci 30:666-671
275. Harauz G, Ishiyama N, Bates IR (2000) Analogous structural motifs in myelin basic protein and in MARCKS. Mol Cell Biochem 209:155-163
276. Soliven B (2001) Calcium signalling in cells of oligodendroglial lineage. Microsc Res Tech 52:672-679
277. Micu I, Jiang Q, Coderre E, Ridsdale A, Zhang L, Woulfe J, Yin X, Trapp BD, McRory JE, Rehak R, Zamponi GW, Wang W, Stys PK (2006) NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia. Nature 439:988-992
278. Sherman DL, Brophy PJ (2005) Mechanisms of axon ensheathment and myelin growth. Nat Rev Neurosci 6:683-690
279. Pritzker LB, Moscarello MA (1998) A novel microtubule independent effect of paclitaxel: the inhibition of peptidylarginine deiminase from bovine brain. Biochim Biophys Acta 1388:154-160
280. Cao L, Sun D, Cruz T, Moscarello MA, Ludwin SK, Whitaker JN (2000) Inhibition of experimental allergic encephalomyelitis in the Lewis rat by paclitaxel. J Neuroimmunol 108:103-111
281. Moscarello MA, Mak B, Nguyen TA, Wood DD, Mastronardi F, Ludwin SK (2002) Paclitaxel (Taxol) attenuates clinical disease in a spontaneously demyelinating transgenic mouse and induces remyelination. Mult Scler 8:130-138